Literature DB >> 30117629

Influence of liver fibrosis on prognosis after surgical resection for resectable single hepatocellular carcinoma.

Suk-Won Suh1, Yoo Shin Choi1.   

Abstract

BACKGROUND: Surgical resection (SR) is recommended for single hepatocellular carcinoma (HCC) in patients with well-preserved liver function. However, unexpected liver fibrosis sometimes found at the SR which leads to a poor outcome. This study investigated the influence of liver fibrosis on prognosis after SR for HCC.
METHODS: A total of 189 patients with Child-Turcotte-Pugh grade A who underwent curative SR for a single HCC <5 cm were evaluated. Patients were assigned to two groups based on the degree of fibrosis (mild or severe), as determined by histological evaluation.
RESULTS: Severe fibrosis was present in 49 patients (25.9%); these patients had greater posthepatectomy liver failure (P = 0.000) and HCC recurrence (P = 0.016). Severe liver fibrosis (hazard ratio (HR) = 1.849, 95% confidence interval (CI) 1.191-2.869; P = 0.006), microvascular invasion (HR = 1.854, 95% CI 1.183-2.906; P = 0.007), and poor histologic grade (HR = 2.097, 95% CI 1.230-3.574; P = 0.007) were related to HCC recurrence.
CONCLUSION: Severe fibrosis can be found even in patients with well-preserved liver function and it leads to poorer early post-operative and late oncologic outcomes, therefore it should be considered before therapeutic decision making of HCC.
© 2018 Royal Australasian College of Surgeons.

Entities:  

Keywords:  Child-Turcotte-Pugh grade A; liver fibrosis; single hepatocellular carcinoma; surgical resection

Mesh:

Year:  2018        PMID: 30117629     DOI: 10.1111/ans.14732

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  5 in total

1.  Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.

Authors:  Xinghao Zhu; Shiqing Jiang; Zongyao Wu; Tonghua Liu; Wei Zhang; Lili Wu; Lijun Xu; Mingliang Shao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

2.  Propofol‑induced HOXA11‑AS promotes proliferation, migration and invasion, but inhibits apoptosis in hepatocellular carcinoma cells by targeting miR‑4458.

Authors:  Furong Song; Jun Liu; Yawei Feng; Yi Jin
Journal:  Int J Mol Med       Date:  2020-07-03       Impact factor: 4.101

3.  Clinical cure and liver fibrosis reversal after postoperative antiviral combination therapy in hepatitis B-associated non-cirrhotic hepatocellular carcinoma: A case report.

Authors:  Xue-Ping Yu; Qi Lin; Zhi-Peng Huang; Wei-Shan Chen; Ming-Hui Zheng; Yi-Juan Zheng; Ju-Lan Li; Zhi-Jun Su
Journal:  World J Clin Cases       Date:  2021-01-26       Impact factor: 1.337

4.  Prognostic nomogram for hepatocellular carcinoma with fibrosis of varying degrees: a retrospective cohort study.

Authors:  Rui Zhang; Jie Chen; Yingyi Jiang; Jian Wang; Shiyao Chen
Journal:  Ann Transl Med       Date:  2020-11

5.  Sub-Classification of Cirrhosis Affects Surgical Outcomes for Early Hepatocellular Carcinoma Independent of Portal Hypertension.

Authors:  Er-Lei Zhang; Jiang Li; Jian Li; Wen-Qiang Wang; Jin Gu; Zhi-Yong Huang
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.